Alembic Pharmaceuticals has launched Pivya, an oral penicillin-class antibiotic, in the US, marking its entry into the branded pharmaceutical market there. Marketed through Alembic Therapeutics LLC, ...

Alembic Pharmaceuticals today announced the first prescription-based sale of Pivya (pivmecillinam) tablets, an oral prescription antibiotic, following its recent commercial launch in the United States ...

Anoxia Medical Inc. and Alembic LLC, both of which make medical catheters, have agreed to stop their patent infringement court fight as they attempt to finalize a settlement in the case. Judge Eumi K.

BEDMINSTER, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Alembic Therapeutics is pleased to announce the U.S. availability of Pivya ® (pivmecillinam) tablets, 185mg, an oral prescription antibiotic. Pivya ...

Feb 5 (Reuters) - Indian drugmaker Alembic Pharmaceuticals (ALEM.NS), opens new tab on Thursday reported lower third‑quarter profit on Thursday after taking a one-time charge linked to India's new ...

Alphabet Inc. is plotting to dramatically expand its presence in India, with the possibility of taking millions of square feet in new office space in Bangalore, India’s tech hub. Google’s parent ...

Google’s parent company is planning a significant expansion in the Indian tech capital of Bengaluru. Alphabet Incorporated has leased one office tower and purchased options on two others in the ...

Fintel reports that on January 15, 2026, Alembic Global initiated coverage of ATI (NYSE:ATI) with a Overweight recommendation. Analyst Price Forecast Suggests 1.04% Downside As of January 14, 2026, ...

Alembic Pharmaceuticals was hit with a patent infringement lawsuit on Dec. 19 in New York Eastern District Court over its planned generic version of the glaucoma treatment LUMIGAN®. The action, ...

Alembic Pharmaceuticals was sued for patent infringement on Dec. 19 in New York Eastern District Court for seeking to market a generic version of glaucoma treatment Lumigan. The action, brought by ...